Certican for Recipients of Kidney From HLA-identical Living Donors
Phase of Trial: Phase IV
Latest Information Update: 17 Aug 2016
At a glance
- Drugs Everolimus (Primary)
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 15 Aug 2016 Status changed from active, no longer recruiting to completed.
- 22 Mar 2015 Planned End Date changed from 1 Aug 2014 to 1 Aug 2015, according to to ClinicalTrials.gov record.
- 22 Mar 2015 Planned primary completion date changed to 1 Aug 2014, according to to ClinicalTrials.gov record.